. Author manuscript; available in PMC: 2020 Aug 4.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2019 Oct 4;20(2):130–135.e1. doi: 10.1016/j.clml.2019.08.013

Table 1. Patient Demographic Characteristics.

Characteristic	Generic MEL	Innovator MEL	P
Patients, n	33	30	NS
Age, y	52 (26-63)	54 (20-68)	NS
Male:Female Sex	22:11 (2:1)	20:10 (2:1)	NS
Pretransplantation Response			NS
CR	19 (58%)	13 (43%)
VGPR	10 (30%)	9 (30%)
PR	4 (12%)	8 (27%)
MEL Dose			NS
200 mg/m²	33	22
140 mg/m²	-	8
CD34, × 10⁶/kg	5.39 (3.22-13.36)	5.2 (3.05-13.58)	NS

Data are presented as n (%) or median (range) except where otherwise noted. Abbreviations: CR = complete response; NS = not significant; PR = partial response; VGPR = very good partial response.